Stay updated with breaking news from Clinical Reader. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new paper in Oxford Open Immunology, published by Oxford University Press, examines prior findings in the field of neuroimmunology that suggest potential treatment strategies for patients suffering long-term symptoms from COVID-19.
Stock photo of doctor and patient A NEW clinical trial could lead to less 'toxic' treatment for blood cancer. Cardiff and Vale University Health Board is implementing a new clinical trial which will give blood cancer patients access to a promising, active lower intensity treatment option. The VICTOR clinical trial, which is funded by Cancer Research UK and led by Dr Richard Dillon from Guy’s Hospital in London, will examine the efficacy of venetoclax-based treatment in treating certain groups of older patients with acute myeloid leukaemia (AML). If found to be effective, the treatm...
E-Mail King's College London researchers have found evidence that minocycline, a widely used antibiotic with anti-inflammatory properties, gave greater improvement in depressive symptoms in patients with treatment resistant depression with low-grade peripheral inflammation. Improvement in depressive symptoms In a four-week randomised clinical MINDEP (MINocycline in DEPression) trial, 39 patients with major depressive disorder were recruited from services linked to South London and Maudsley NHS Foundation Trust (SLaM) and via public advertisement. The trial took place at the NIHR / Wellco...
Antibiotic may improve depressive symptoms in people with low-level inflammation: Study ANI | Updated: Jan 28, 2021 11:29 IST Washington [US], January 28 (ANI): While antibiotics are widely used to treat bacterial infections and other illnesses, a new research suggested that minocycline, an antibiotic with anti-inflammatory properties, improved depressive symptoms in patients with low-grade peripheral inflammation. The findings of the study were published in the journal 'Neuropsychopharmacology'. According to the study led by King's College London researc...
Dr Ed Day Biography Dr Day is the UK government’s drug Recovery Champion. He is a clinician who has led the orientating of clinical practice towards recovery and has a research interest in recovery support services and mutual aid. He is a Clinical Reader in Addiction Psychiatry at the Institute for Mental Health at the University of Birmingham, and a Consultant Psychiatrist with Birmingham and Solihull Mental Health NHS Trust. He has been an expert advisor on addiction issues to Public Health England and the Department for Transport and is currently the President of the Society for the ...